class name | count |
---|---|
asterids | 66 |
eudicotyledons | 1 |
class name | count |
---|---|
Apocynaceae | 35 |
Rubiaceae | 31 |
Menispermaceae | 1 |
br08003 Category | # of metabolite |
---|---|
Indole alkaloids | 5 |
br08003 Category | KEGG ID | KNApSAcK ID |
---|---|---|
Indole alkaloids | C09024 | C00001678 |
Indole alkaloids | C09037 | C00001690 |
Indole alkaloids | C10904 | C00001696 |
Indole alkaloids | C11683 | C00025138 |
Indole alkaloids | C11682 | C00025214 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00001678
![]() |
Ajmalicine
|
CHEMBL122404
CHEMBL123325 CHEMBL498734 CHEMBL486933 CHEMBL1604074 CHEMBL2079609 |
C005709
|
32 / 28 / 31 | 1 / 4 |
![]() |
C00001690
![]() |
Aricine
|
CHEMBL525626
|
C017997
|
![]() |
||
C00001696
![]() |
Cabucine
|
CHEMBL525626
|
![]() |
|||
C00001751
![]() |
Mitragynine
|
CHEMBL58496
CHEMBL299031 CHEMBL107364 |
C001801
|
1 / 0 / 0 | 3 / 0 |
![]() |
C00025133
![]() |
14alpha-Hydroxy-3-isorauniticine
|
![]() |
||||
C00025134
![]() |
14beta-Hydroxy-3-isorauniticine
|
![]() |
||||
C00025137
![]() |
19-Epi-3-isoajmalicine
/ 3-Iso-19-epiajmalicine |
CHEMBL122404
CHEMBL123325 CHEMBL498734 CHEMBL486933 CHEMBL1604074 CHEMBL2079609 |
32 / 28 / 31 |
![]() |
||
C00025138
![]() |
19-Epiajmalicine
/ 19-epi-Ajmalicine / (+)-19-epi-Ajmalicine |
CHEMBL122404
CHEMBL123325 CHEMBL498734 CHEMBL486933 CHEMBL1604074 CHEMBL2079609 |
32 / 28 / 31 |
![]() |
||
C00025145
![]() |
3-Isoajmalicine
|
CHEMBL122404
CHEMBL123325 CHEMBL498734 CHEMBL486933 CHEMBL1604074 CHEMBL2079609 |
32 / 28 / 31 |
![]() |
||
C00025146
![]() |
3-Isorauniticine
|
CHEMBL122404
CHEMBL123325 CHEMBL498734 CHEMBL486933 CHEMBL1604074 CHEMBL2079609 |
32 / 28 / 31 |
![]() |
||
C00025161
![]() |
Corynantheidine
|
CHEMBL60533
CHEMBL327134 CHEMBL1668781 CHEMBL1668783 |
2 / 0 / 0 |
![]() |
||
C00025166
![]() |
Dihydrocorynantheine
/ 18,19-Dihydrocorynantheine |
CHEMBL60533
CHEMBL327134 CHEMBL1668781 CHEMBL1668783 |
2 / 0 / 0 |
![]() |
||
C00025174
![]() |
Hirsuteine
/ 3-Epicorynantheine |
CHEMBL326900
|
![]() |
|||
C00025175
![]() |
Hirsutine
/ Hirsutine(Mitragyna) |
CHEMBL60533
CHEMBL327134 CHEMBL1668781 CHEMBL1668783 |
C038369
|
2 / 0 / 0 |
![]() |
|
C00025179
![]() |
Isocorynantheidine
|
CHEMBL60533
CHEMBL327134 CHEMBL1668781 CHEMBL1668783 |
2 / 0 / 0 |
![]() |
||
C00025182
![]() |
Isopaynantheine
/ 3-Isopaynantheine |
![]() |
||||
C00025183
![]() |
Isoreserpiline
/ Neoreserpiline |
CHEMBL1622689
|
![]() |
|||
C00025191
![]() |
Mitrajavine
|
![]() |
||||
C00025194
![]() |
Paynantheine
/ Indolo[2,3-a]quinolizine |
![]() |
||||
C00025202
![]() |
Ervine
/ Rauniticine |
CHEMBL122404
CHEMBL123325 CHEMBL498734 CHEMBL486933 CHEMBL1604074 CHEMBL2079609 |
32 / 28 / 31 |
![]() |
||
C00025207
![]() |
Reserpilin
/ Elliptamine / Reserpiline / (-)-Reserpiline |
CHEMBL1622689
|
![]() |
|||
C00025209
![]() |
Speciociliatin
/ Speciociliatine |
CHEMBL58496
CHEMBL299031 CHEMBL107364 |
1 / 0 / 0 |
![]() |
||
C00025211
![]() |
Speciogynin
/ Speciogynine |
CHEMBL58496
CHEMBL299031 CHEMBL107364 |
1 / 0 / 0 |
![]() |
||
C00025214
![]() |
Tetrahydroalstonine
|
CHEMBL122404
CHEMBL123325 CHEMBL498734 CHEMBL486933 CHEMBL1604074 CHEMBL2079609 |
32 / 28 / 31 |
![]() |
||
C00025215
![]() |
Tetrahydroalstonine N-oxide
/ (4R)-Tetrahydroalstonine N-oxide |
![]() |
||||
C00026851
![]() |
Darcyribeirine
|
![]() |
||||
C00049103
![]() |
Akuammigine
|
CHEMBL122404
CHEMBL123325 CHEMBL498734 CHEMBL486933 CHEMBL1604074 CHEMBL2079609 |
32 / 28 / 31 |
![]() |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00001678
C00001751
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00001751
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00001751
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#613985 | Beta-thalassemia |
P68871
|
#603902 | Beta-thalassemia, dominant inclusion body type |
P68871
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#140700 | Heinz body anemias |
P68871
|
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#603903 | Sickle cell anemia |
P68871
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00228 | Thalassemia |
P68871
(related)
|
H00229 | Sickle cell anemia (SCA) |
P68871
(related)
|
H00020 | Colorectal cancer |
P68871
(marker)
|
H00022 | Bladder cancer |
P68871
(marker)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|